Treatment demand indicator (TDI) standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries
Introduction
This Manual is a revised edition of the Treatment demand indicator (TDI) protocol version 2.0 and presents updated guidelines for reporting data on people entering drug treatment in Europe. The TDI is one of five key epidemiological indicators which provide a common European methodology for collecting and reporting core data on the number and profiles of those entering specialised drug treatment each year. TDI data are routinely used in EMCDDA analysis of the drug situation in Europe, helping to identify trends and patterns in problem drug use and to assess the use and uptake of treatment facilities.
Table of contents
- Introduction
- Guidelines
- Methodological and ethical issues
- Annexes
Translations
- Arabic (translation by the Egyptian Ministry of Health and Population, General Secretariat of Mental Health and Addiction treatment (GSMHAT), common initiative with the Pompidou Group)
- Bulgarian (translated by the Bulgarian national focal point)
- Croatian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Finnish (translated by the Finnish national focal point)
- French (translation verified by the French national focal point)
- Greek (translated by the Greek national focal point)
- Latvian (translation verified by the Latvian national focal point)
- Albanian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Bosnian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Macedonian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)
- Serbian (translated and produced within the framework of regional projects implemented by the EMCDDA’s Reitox and International cooperation unit)